119 related articles for article (PubMed ID: 29253818)
1. ASP49-phospholipase A
de Barros NB; Aragão Macedo SR; Ferreira AS; Tagliari MP; Kayano AM; Nicolete LDF; Soares AM; Nicolete R
Int Immunopharmacol; 2018 Feb; 55():128-132. PubMed ID: 29253818
[TBL] [Abstract][Full Text] [Related]
2. Liposomes containing an ASP49-phospholipase A2 from Bothrops jararacussu snake venom as experimental therapy against cutaneous leishmaniasis.
de Barros NB; Macedo SRA; Ferreira AS; Tagliari MP; Zanchi FB; Kayano AM; Soares AM; Nicolete R
Int Immunopharmacol; 2016 Jul; 36():225-231. PubMed ID: 27174621
[No Abstract] [Full Text] [Related]
3. The effect of phospholipase A2 from Crotalus durissus collilineatus on Leishmania (Leishmania) amazonensis infection.
Passero LF; Laurenti MD; Tomokane TY; Corbett CE; Toyama MH
Parasitol Res; 2008 Apr; 102(5):1025-33. PubMed ID: 18180953
[TBL] [Abstract][Full Text] [Related]
4. BE-I-PLA2, a novel acidic phospholipase A2 from Bothrops erythromelas venom: isolation, cloning and characterization as potent anti-platelet and inductor of prostaglandin I2 release by endothelial cells.
de Albuquerque Modesto JC; Spencer PJ; Fritzen M; Valença RC; Oliva ML; da Silva MB; Chudzinski-Tavassi AM; Guarnieri MC
Biochem Pharmacol; 2006 Jul; 72(3):377-84. PubMed ID: 16750518
[TBL] [Abstract][Full Text] [Related]
5. BnSP-7 toxin, a basic phospholipase A2 from Bothrops pauloensis snake venom, interferes with proliferation, ultrastructure and infectivity of Leishmania (Leishmania) amazonensis.
Nunes DC; Figueira MM; Lopes DS; De Souza DL; Izidoro LF; Ferro EA; Souza MA; Rodrigues RS; Rodrigues VM; Yoneyama KA
Parasitology; 2013 Jun; 140(7):844-54. PubMed ID: 23442579
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of a phospholipase A
Salvador GH; Dos Santos JI; Lomonte B; Fontes MR
Biochimie; 2017 Feb; 133():95-102. PubMed ID: 28034717
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of amiodarone in treatment of cutaneous leishmaniasis caused by Leishmania major.
Bemani E; Oryan A; Bahrami S
Exp Parasitol; 2019 Oct; 205():107747. PubMed ID: 31442454
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and structural investigations of Bothropstoxin-II, a myotoxic Asp49 phospholipase A2 from Bothrops jararacussu venom.
Murakami MT; Lourenzoni MR; Arruda EZ; Tomaz MA; Viçoti MM; Abrego JR; Melo PA; Arni RK
Protein Pept Lett; 2008; 15(9):1002-8. PubMed ID: 18991778
[TBL] [Abstract][Full Text] [Related]
9. Muscle phospholipid hydrolysis by Bothrops asper Asp49 and Lys49 phospholipase A₂ myotoxins--distinct mechanisms of action.
Fernández J; Caccin P; Koster G; Lomonte B; Gutiérrez JM; Montecucco C; Postle AD
FEBS J; 2013 Aug; 280(16):3878-86. PubMed ID: 23763831
[TBL] [Abstract][Full Text] [Related]
10. Dissociation of enzymatic and pharmacological properties of piratoxins-I and -III, two myotoxic phospholipases A2 from Bothrops pirajai snake venom.
Soares AM; Andrião-Escarso SH; Bortoleto RK; Rodrigues-Simioni L; Arni RK; Ward RJ; Gutiérrez JM; Giglio JR
Arch Biochem Biophys; 2001 Mar; 387(2):188-96. PubMed ID: 11370840
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapeutic effects of chitin in comparison with chitosan against Leishmania major infection.
Hoseini MH; Moradi M; Alimohammadian MH; Shahgoli VK; Darabi H; Rostami A
Parasitol Int; 2016 Apr; 65(2):99-104. PubMed ID: 26518128
[TBL] [Abstract][Full Text] [Related]
12. Skin-derived macrophages from Leishmania major-susceptible mice exhibit interleukin-12- and interferon-gamma-independent nitric oxide production and parasite killing after treatment with immunostimulatory DNA.
von Stebut E; Belkaid Y; Nguyen B; Wilson M; Sacks DL; Udey MC
J Invest Dermatol; 2002 Sep; 119(3):621-8. PubMed ID: 12230504
[TBL] [Abstract][Full Text] [Related]
13. Toxicity of phospholipases A2 D49 (6-1 and 6-2) and K49 (Bj-VII) from Bothrops jararacussu venom.
Bonfim VL; de Carvalho DD; Ponce-Soto LA; Kassab BH; Marangoni S
Cell Biol Toxicol; 2009 Dec; 25(6):523-32. PubMed ID: 18975118
[TBL] [Abstract][Full Text] [Related]
14. Repeated intravenous injection of adipose tissue derived mesenchymal stem cells enhances Th1 immune responses in Leishmania major-infected BALB/c mice.
Zanganeh E; Soudi S; Zavaran Hosseini A; Khosrojerdi A
Immunol Lett; 2019 Dec; 216():97-105. PubMed ID: 31622634
[TBL] [Abstract][Full Text] [Related]
15. A natural cell-penetrating nanopeptide combined with pentavalent antimonial as experimental therapy against cutaneous leishmaniasis.
Valentim Silva JR; de Barros NB; Aragão Macedo SR; Ferreira ADS; Moreira Dill LS; Zanchi FB; do Nascimento JR; Fernandes do Nascimento FR; Lourenzoni MR; de Azevedo Calderon L; Soares AM; Nicolete R
Exp Parasitol; 2020 Oct; 217():107934. PubMed ID: 32698075
[TBL] [Abstract][Full Text] [Related]
16. M1 homeopathic complex trigger effective responses against Leishmania (L) amazonensis in vivo and in vitro.
Nascimento KF; de Santana FR; da Costa CRV; Kaplum V; Volpato H; Nakamura CV; Bonamin LV; de Freitas Buchi D
Cytokine; 2017 Nov; 99():80-90. PubMed ID: 28738234
[TBL] [Abstract][Full Text] [Related]
17. Antiparasitic effects induced by polyclonal IgY antibodies anti-phospholipase A
Borges IP; Silva MF; Santiago FM; de Faria LS; Júnior ÁF; da Silva RJ; Costa MS; de Freitas V; Yoneyama KAG; Ferro EAV; Lopes DS; Rodrigues RS; de Melo Rodrigues V
Int J Biol Macromol; 2018 Jun; 112():333-342. PubMed ID: 29391226
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of a myotoxic Asp49-phospholipase A2 with low catalytic activity: Insights into Ca2+-independent catalytic mechanism.
Corrêa LC; Marchi-Salvador DP; Cintra AC; Sampaio SV; Soares AM; Fontes MR
Biochim Biophys Acta; 2008 Apr; 1784(4):591-9. PubMed ID: 18261474
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection.
Pereira WK; Lonardoni MV; Grespan R; Caparroz-Assef SM; Cuman RK; Bersani-Amado CA
J Infect; 2005 Aug; 51(2):157-64. PubMed ID: 16038768
[TBL] [Abstract][Full Text] [Related]
20. Renal and antibacterial effects induced by myotoxin I and II isolated from Bothrops jararacussu venom.
Barbosa PS; Martins AM; Havt A; Toyama DO; Evangelista JS; Ferreira DP; Joazeiro PP; Beriam LO; Toyama MH; Fonteles MC; Monteiro HS
Toxicon; 2005 Sep; 46(4):376-86. PubMed ID: 16115661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
